VN1R65P

Across TCGA pan-cancer cohorts, VN1R65P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated VN1R65P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher VN1R65P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated VN1R65P expression acts as an unfavorable survival marker, although some lineages such as ESCA and STAD show a favorable association.

ACC, LUAD, and BRCA are the cancer types where VN1R65P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.667	<.001	135	view →
LUAD	OS	Tertile	II,III,IV	0.193	0.711	<.001	99	view →
BRCA	DFS	Tertile	All	0.160	0.529	<.001	84	view →
BLCA	OS	Tertile	III,IV	0.051	0.684	<.001	72	view →
KIRP	DFS	Tertile	IV	0.088	0.502	<.001	45	view →
KIRC	DFS	Tertile	IV	0.127	0.630	.039	18	view →
ESCA	DFS	Tertile	III,IV	0.769	0.367	.019	18	view →
THCA	DFS	Tertile	III,IV	0.145	0.765	.003	18	view →
LGG	DFS	Tertile	All	0.405	0.761	.022	9	view →
STAD	OS	Tertile	II,III,IV	0.788	0.630	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

VN1R65P–ACC (DFS)

Open the ACC breakdown →